Interpace Biosciences
IDXG
#10519
Rank
HK$0.28 B
Marketcap
HK$47.47
Share price
-3.20%
Change (1 day)
523.12%
Change (1 year)

Earnings for Interpace Biosciences (IDXG)

Earnings in 2026 (TTM): HK$31.52 Million

According to Interpace Biosciences's latest financial reports the company's current earnings are HK$36.14 Million. In 2025 the company made an earning of HK$30.93 Million a decrease over its 2024 earnings that were of HK$67.63 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Interpace Biosciences from 1997 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) HK$31.52 M1.89%
2025 HK$30.93 M-54.26%
2024 HK$67.63 M303.23%
2023 HK$16.77 M-144.63%
2022 -HK$37.59 Million-60.98%
2021 -HK$96.33 Million-52.04%
2020 -HK$0.21 Billion-2.68%
2019 -HK$0.21 Billion121.84%
2018 -HK$93.03 Million-6.07%
2017 -HK$99.04 Million96.31%
2016 -HK$50.45 Million-86.7%
2015 -HK$0.38 Billion382.48%
2014 -HK$78.64 Million134.35%
2013 -HK$33.56 Million323.89%
2012 -HK$7.92 Million-79.01%
2011 -HK$37.72 Million29.08%
2010 -HK$29.22 Million-82.57%
2009 -HK$0.17 Billion-39.28%
2008 -HK$0.28 Billion146.45%
2007 -HK$0.12 Billion-269.18%
2006 HK$66.21 M-131.08%
2005 -HK$0.22 Billion-177.16%
2004 HK$0.27 B78.33%
2003 HK$0.15 B-142.02%
2002 -HK$0.37 Billion-469.63%
2001 HK$99.67 M-68.92%
2000 HK$0.32 B140.45%
1999 HK$0.13 B
1997 HK$18.82 M